ARTICLE | Clinical News
Cell culture based pandemic influenza vaccine: Phase II started
May 28, 2012 7:00 AM UTC
Vivalis S.A. (Euronext:VLS, Nantes, France) said Kaketsuken began in April a Japanese Phase II trial to evaluate a cell culture-based pandemic flu vaccine. In 2009, GlaxoSmithKline and Kaketsuken (fo...